Takayuki Yoshino Selected Research

Takayuki Yoshino Research Topics

Disease

171	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 09/2003
153	Neoplasms (Cancer) 04/2024 - 09/2004
29	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2005
29	Stomach Neoplasms (Stomach Cancer) 10/2023 - 01/2006
21	Disease Progression 04/2024 - 02/2007
21	Colonic Neoplasms (Colon Cancer) 03/2024 - 02/2011
18	Microsatellite Instability 01/2024 - 11/2018
16	Neutropenia 01/2023 - 07/2006
13	Adenocarcinoma 10/2023 - 10/2002
10	Fatigue 01/2022 - 08/2012
8	Renal Cell Carcinoma (Grawitz Tumor) 06/2022 - 08/2012
7	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 12/2016
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 02/2016
7	Febrile Neutropenia 12/2021 - 04/2008
6	Esophageal Squamous Cell Carcinoma 01/2024 - 03/2016
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2024 - 12/2020
5	Rectal Neoplasms (Rectal Cancer) 03/2024 - 06/2016
5	Carcinoma (Carcinomatosis) 01/2023 - 10/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 10/2006
5	Nausea 01/2023 - 01/2008
5	Diarrhea 01/2023 - 07/2006
4	Exanthema (Rash) 01/2023 - 01/2013
4	Hypertension (High Blood Pressure) 01/2023 - 01/2013
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 04/2008
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2024 - 06/2020
3	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2015
3	Squamous Cell Carcinoma of Head and Neck 10/2023 - 05/2013
3	Intestinal Perforation 01/2023 - 01/2020
3	Hemorrhage 01/2023 - 01/2018
3	Testicular Neoplasms (Testicular Cancer) 06/2018 - 08/2012
3	Ascites 01/2018 - 10/2008

Drug/Important Bio-Agent (IBA)

43	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2011
35	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 09/2007
35	Bevacizumab (Avastin)FDA Link 03/2024 - 08/2007
33	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 12/2005
30	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 01/2006
25	Cetuximab (Erbitux)FDA Link 03/2024 - 06/2009
25	trifluridine tipiracil drug combinationIBA 01/2024 - 10/2012
23	ErbB Receptors (EGF Receptor)IBA 03/2024 - 05/2009
21	Circulating Tumor DNAIBA 04/2024 - 01/2017
21	Monoclonal AntibodiesIBA 01/2024 - 08/2007
17	regorafenibIBA 02/2024 - 01/2013
15	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2018
13	Panitumumab (Vectibix)FDA Link 02/2024 - 05/2009
12	NivolumabIBA 03/2024 - 01/2019
12	Leucovorin (Folinic Acid)FDA Link 12/2023 - 07/2006
12	pembrolizumabIBA 03/2023 - 01/2019
11	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2011
11	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2005
11	RamucirumabIBA 11/2021 - 05/2015
10	ParaffinIBA 01/2022 - 01/2011
9	encorafenibIBA 03/2024 - 01/2017
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 08/2007
9	Formaldehyde (Formol)FDA Link 01/2022 - 01/2011
8	binimetinibIBA 03/2024 - 10/2019
8	AntibodiesIBA 01/2022 - 01/2011
7	Cell-Free Nucleic AcidsIBA 03/2024 - 08/2015
7	Docetaxel (Taxotere)FDA Link 01/2024 - 01/2006
6	Gemcitabine FDA Link 01/2023 - 12/2005
6	PlatinumIBA 10/2022 - 04/2008
6	human ERBB2 proteinIBA 01/2022 - 01/2015
6	Codon (Codons)IBA 12/2019 - 11/2011
5	Antineoplastic Agents (Antineoplastics)IBA 08/2023 - 01/2018
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2023 - 01/2015
5	Phosphotransferases (Kinase)IBA 07/2023 - 01/2018
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2023 - 01/2018
5	napabucasinIBA 01/2023 - 01/2018
5	Capecitabine (Xeloda)FDA Link 10/2022 - 02/2020
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 12/2005
5	Sunitinib (Sutent)FDA Link 06/2020 - 03/2012
4	Epidermal Growth Factor (EGF)IBA 04/2024 - 12/2012
4	Sodium Glutamate (Accent)IBA 03/2024 - 01/2021
4	Trastuzumab (Herceptin)FDA Link 01/2023 - 11/2021
4	afliberceptIBA 01/2023 - 08/2013
4	LigandsIBA 01/2022 - 05/2017
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2015
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2016
3	Mitogen-Activated Protein KinasesIBA 05/2023 - 01/2017
3	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2021
3	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 10/2019
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 05/2015
3	trastuzumab deruxtecanIBA 01/2023 - 01/2021
3	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 11/2016
3	NucleosidesIBA 04/2021 - 01/2016
3	Carcinoembryonic AntigenIBA 01/2020 - 10/2008
3	Therapeutic UsesIBA 01/2018 - 03/2016

Therapy/Procedure

107	Therapeutics 04/2024 - 09/2003
80	Drug Therapy (Chemotherapy) 03/2024 - 12/2005
14	Immunotherapy 02/2024 - 07/2016
12	Adjuvant Chemotherapy 03/2024 - 01/2013
10	Precision Medicine 03/2024 - 11/2016
10	Radiotherapy 03/2024 - 12/2005
9	Chemoradiotherapy 03/2024 - 01/2008
7	Genomic Medicine 12/2022 - 09/2018
6	Combination Drug Therapy (Combination Chemotherapy) 01/2024 - 01/2006
4	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 08/2012
3	Neoadjuvant Therapy 03/2024 - 03/2016
3	Aftercare (After-Treatment) 01/2023 - 05/2021
3	Hepatectomy 10/2021 - 05/2013